Table 1 The clinical and pathological characteristics of 42 cases of prostate cancer and prostate hyperplasia
| Â | group | clinical and pathological characteristics |
|---|---|---|
Mean age (range) | Prostate cancer | 68.40 ± 9.55 (57–85) |
|  | prostate hyperplasia | 64.18 ± 11.74 (45–81) |
Histologic examination | Prostate cancer | adenocarcinoma |
| Â | prostate hyperplasia | Fibromuscuadenomaoid node, adenomaoid node, leiomyomaoid node and fibrohemangioid |
Pathological evaluation | Prostate cancer | Gleason grade IV 10(45.5%) and Gleason grade V 12(54.5%) |
| Â | prostate hyperplasia | Moderate hyperplasia 12(60%) and severe hyperplasia 8(40%) |
Volume(cm3) | Prostate cancer | 78.53 ± 29.75 |
|  | prostate hyperplasia | 45.25 ± 18.97 |
Local invasion and metastasis | Prostate cancer | Local invasion 14(63.4) and metastasis 2(9%) |
| Â | prostate hyperplasia | no |
Level of prostate specific antigen in blood(ng/ml) | Prostate cancer | 68.57 ± 50.43 |
|  | prostate hyperplasia | 20.21 ± 3.27 |